Harbin Kexin Bicheng Pharmaceutical Technology Development

Harbin Kexin Bicheng Pharmaceutical Technology Development is a Chinese pharmaceutical research and development company specializing in advanced drug formulation and delivery technologies. The company focuses on the design and development of solid dosage forms, particularly orally disintegrating tablets (ODTs), sustained-release, and controlled-release preparations. Harbin Kexin Bicheng acquired key formulation patents from its affiliate CoSci Med-Tech (Beijing Kexin Bicheng), including technologies for metoclopramide and dioscin orally disintegrating tablets. The company leverages these drug delivery platforms to improve patient compliance and therapeutic efficacy across various clinical indications, including gastrointestinal disorders and cardiovascular diseases.